Bid BH3-R8 - 0.5 mg
- Cat.Number : AS-61715
- Manufacturer Ref. :
-
Availability :
In stock
The Bid BH3 is a pro-apoptotic member of the 'BH3-only' subset of BCL-2 family proteins that constitute a critical control point in apoptosis. r8BIDBH3 is lethal to human leukemia cell lines that expresse Bcl-2. The Bcl-2 antagonists may have the potential to be efficacious in cancer therapy. Poly-D-arginine (d-isomer as denoted by rrrrrrrr) is fused to the Bid BH3 peptide to facilitate cellular uptake of the peptide.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
You may also be interested in the following product(s)
![IMG-EN-AS-60841-01.jpg](/assets/cache/97e4de79-5fea-4e8c-80e4-52a2f395a859/500x500/as-60841-img-en-as-60841-01.jpg)
![IMG-EN-AS-65581-01.jpg](/assets/cache/f034fc2f-5b8d-4cf9-a312-27ed764eaac5/500x500/as-65581-img-en-as-65581-01.jpg)
![IMG-EN-AS-60628-01.jpg](/assets/cache/495c684d-9b17-46dd-a1cb-c27499e52d88/500x500/as-60628-img-en-as-60628-01.jpg)
References
Anti-tumor chemotherapy utilizing peptide-based approaches--apoptotic pathways, kinases, and proteasome as targets
Arch Immunol Ther Exp (Warsz) . 2005 Jan 31 ; 53(1) 47
- F. Mendoza
- et al
Pharmacological manipulation of Bcl-2 family members to control cell death
J Clin Invest . 2005 Oct 01 ; 115(10) 2648 | DOI : 10.1172/JCI26250
- A. Letai